US 12018074
Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 12018074 (Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases) held by CHEMOMAB LTD. expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CHEMOMAB LTD.
- Grant date
- Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P